medline.ch Onkologie Urologische Tumoren

	Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway. Clin Exp Med Stensland M, Bru KF, Austdal M, Dahl IH, Jonsdottir K, Lende TH, Heimvik C, Elve I, Omdal R, van der Giezen M, Kvivik I, Tangeland B, Davidsen L, Hashemi M, Cais A, van Dijk KJ, Seyoum Y, Blåfjelldal V, Sola ST, Papadopoulos A, Kiriakidou N, Ioakeimidis I, Diou C, Sarafis I, Delopoulos A, Janssen EAM, Gilje B, Tjensvoll K. PMID: 41655181 [PubMed - as supplied by publisher]
	Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. Sci Rep Li S, Qin J, Sun Q, Zhao H, Xiong Y, Wang Y, Han Y, Zhang J, Zhang W, Shen M, Yang F, Ren B, Zhou L, Li R, Hui Z, Tian X, Cao S, Du W, Yu W, Liu L, Zhang X, Ren X. PMID: 41654611 [PubMed - as supplied by publisher]
	Statin use and outcomes in advanced prostate cancer:Secondary analysis of the SPARTAN trial. Urol Oncol Mousa A, Chavarriaga J, Lajkosz K, Penn LZ, Khurram N, Hamilton RJ. PMID: 41654482 [PubMed - as supplied by publisher]
	Predicting Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Model Development and Evaluation in an International Cohort Study. Clin Genitourin Cancer Weiner AB, Martin SC, Wilhalme H, Bailey AV, Kwan L, Awamlh BAHA, Zhao Z, Verze P, Ippolito J, La Rocca R, Sibert NT, Barocas DA, Belin TR, Elashoff D, Kowalski C, Foster C, Moore C, Litwin MS, True North Global Registry. PMID: 41654456 [PubMed - as supplied by publisher]
	Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol Contieri R, Paciotti M, Uleri A, Saita A, Taverna G, Sedigh O, Barra S, Colombo P, Porreca A, Beatrici E, Fasulo V, Avolio PP, Frego N, Finocchiaro A, Cella L, Collura D, Cieri M, Guazzoni G, Buffi NM, Lughezzani G, Casale P, Lazzeri M, Hurle R. PMID: 41654427 [PubMed - as supplied by publisher]
	Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain. Clin Transl Oncol Romero Zoghbi SE, López Campos F, Ocanto A, Sanz-Rosa D, Thuissard-Vasallo IJ, Andreu Vázquez C, Laria C, Fernández Ibiza J, Andreescu Yagüe J, Krumina E, Mateos M, Dzhugashvili M, Glaría LA, Gonsalves D, Fernández C, Esteban D, de la Fuente JB, González Ferreira JA, Ristori A, Rivas D, López E, Bezares Alarcón AB, Aakki L, Larrea L, García Cuesta JÁ, Zamboglou C, Alongi F, García García R, Couñago F. PMID: 41653361 [PubMed - as supplied by publisher]
	Kidney cancer and occupational agricultural exposures in the AGRIculture and CANcer cohort. Int J Epidemiol Nassar C, Boulanger M, Baldi I, Tual S, Bara S, Lebailly P, Clin B, AGRICAN group. PMID: 41653060 [PubMed - indexed for MEDLINE]
	The emerging role of TROP2 as a diagnostic and prognostic biomarker in bladder tumor. Cancer Cell Int Ye M, Badehnoosh B. PMID: 41652619 [PubMed - as supplied by publisher]
	A Systematic Review of the Economic Burden of Prostate Cancer: Direct and Indirect Cost Perspectives. Pharmacoeconomics Darbà J, Ascanio M, Rodríguez A. PMID: 41652274 [PubMed - as supplied by publisher]
	Inter- and intra-rater variability of MRI-based lesion size measurements in active surveillance for prostate cancer: a multicentre study. Eur Radiol Englman C, Adebusoye B, Cosenza M, Del Prete A, Dickinson L, Imperiale G, Leni R, Gandaglia G, De Cobelli F, Mallett S, Kirkham A, Moore CM, Giganti F, Brembilla G. PMID: 41652236 [PubMed - as supplied by publisher]
	Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study. Br J Cancer Blanchet B, Puszkiel A, Jouinot A, Bennamoun M, Maillet D, Borchiellini D, Laguerre B, Pannier D, Gross-Goupil M, Chevreau C, Barthélémy P, Tournigand C, Coquan E, Gravis G, Lepicard E, Fridman WH, Sautes-Fridman C, Oudard S, Sun CM, Vano YA. PMID: 41652222 [PubMed - as supplied by publisher]
	Dosimetric study of dose de-escalation using MRI-guidance for Pd-103 low-dose-rate brachytherapy in prostate cancer. Brachytherapy Xue A, Wang L, Akerman M, Gogineni A, Coelho A, Potters L, Parashar B. PMID: 41651735 [PubMed - as supplied by publisher]
	Diagnostic performance of urinary biomarker tests in detecting bladder cancer: A systematic review, meta-analysis, and network meta-analysis. Urology Siguencia F, Heard J, Smith SM, Pagano I, Furuya H, Wu X, Ahdoot M, Rosser CJ. PMID: 41651230 [PubMed - as supplied by publisher]
	Validation and context-dependent effects of a prostate cancer polygenic risk score in the All of Us Research Program. Am J Hum Genet Cheng S, Suger AH, Goss LB, Zhang J, Fuller H, Guo B, Lindström S, Darst BF. PMID: 41650938 [PubMed - indexed for MEDLINE]
	Construction and validation of a competing risk model for specific survival of patients with second primary malignancies after prostate cancer. Medicine (Baltimore) Bao EH, Yang Y, Wang JH, Li Y, Liu Y, Yang L, Hao P. PMID: 41650062 [PubMed - indexed for MEDLINE]
	Analysis of the molecular mechanism underlying di(2-ethylhexyl) phthalate-induced bladder carcinogenesis via network toxicology and molecular docking approaches: An observational study. Medicine (Baltimore) Jiang M, Sun C, Wang B, Huang Q, Hu Q, Che X. PMID: 41650055 [PubMed - indexed for MEDLINE]
	Clonal hematopoiesis after 177Lu-PSMA-617 radioligand therapy in prostate cancer. Clin Cancer Res Munzur AD, Herberts C, Kwan EM, Emmett L, Sandhu S, Buteau JP, Iravani A, Joshua AM, Francis RJ, Lee ST, Scott AM, Martin AJ, Stockler MR, Zhang AY, Williams SG, Bernales CQ, Donnellan G, Koudjanian M, Parekh K, Bacon JVW, Karsan A, Azad AA, Davis ID, Hofman MS, Wyatt AW. PMID: 41649873 [PubMed - as supplied by publisher]
	Oncological Safety of Bladder Preservation in Elderly Patients with Muscle-Invasive Bladder Cancer. Ann Surg Oncol Mehmud I, Zhang Y, Wu S, Zhang S. PMID: 41649780 [PubMed - as supplied by publisher]
	[Neoadjuvant therapy and complete response of muscle-invasive bladder cancer: may the urinary bladder be preserved?]. Urologie Bolenz C, Zengerling F, Kübler H, Hahn O. PMID: 41649558 [PubMed - as supplied by publisher]
	[Current diagnostics and treatment of penile cancer]. Urologie Dräger DL, Protzel C. PMID: 41649557 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 175821

Seite 1 von 8792

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung